Clinical Impact, Reactogenicity, and Immunogenicity After the First CoronaVac Dose in Kidney Transplant Recipients. Medina-Pestana J, Cristelli MP, Viana LA, Foresto RD, et al. Transplantation 2021 Jul 20. pii: 00007890-900000000-95193.

Read + Share

Amedeo Smart

Independent Medical Education

Medina-Pestana J, Cristelli MP, Viana LA, Foresto RD, et al. Clinical Impact, Reactogenicity, and Immunogenicity After the First CoronaVac Dose in Kidney Transplant Recipients. Transplantation 2021 Jul 20. pii: 00007890-900000000-95193.
PMID: 34292214